Triple therapy with rituximab, intravenous immunoglobulin, and intravitreal corticosteroids for melanoma-associated retinopathy: ttriic does the trick

Conclusion: This is the first reported case of the utility of triple therapy with rituximab, intravenous immunoglobulin, and intravitreal steroids for successful management of melanoma-associated retinopathy as demonstrated by improvement in acuity, symptoms, visual fields, and electroretinography.
Source: Retinal Cases and Brief Reports - Category: Opthalmology Tags: Case Report Source Type: research